Daily as of 3 Nov 16:00 ET
- Price
- below both $81.08 vs 50 $101.24 / 200 $92.18
- Projection
- 💀Death cross estimated in 12 to 18 bars
- Test
- No active test
- Last cross
- 🟨Golden cross 14 Jul 2025 · projected 29 bars out
INBX | Inhibrx BiosciencesNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$81.08
+$8.92 (+12.36%)
Inhibrx Biosciences (INBX) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2024.
Right now the daily is the chart to watch. The 50 SMA has sat above the 200 since Jul 2025, but the two have been closing on each other and a death cross is projected within 20 bars. Price sits below the 50 and the 200 on the daily and the 4-hour.
Timeframe summary
Weekly
No weekly data
4-hour as of 3 Nov 13:30 ET
- Price
- below both $81.08 vs 50 $90.19 / 200 $96.52
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 23 Oct 2026 bar 1 · projected 30 bars out · tested 2 bars
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 23 Oct 2026 | 💀Death | 4-hour | 30 bars out | 2 bar cross test |
| 2 Sep 2026 | 🟨Golden | 4-hour | 28 bars out | Not tested |
| 28 Jul 2026 | 💀Death | 4-hour | 19 bars out | Not tested |
| 27 Apr 2026 | 🟨Golden | 4-hour | 29 bars out | Not tested |
| 16 Mar 2026 | 💀Death | 4-hour | 17 bars out | Not tested |
About INBX
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$25.8M
4-hour coverageYes, since Oct 2025
History on recordSince 2024
SectorHealthcare
Cap bandsmall